CONATUS PHARMACEUTICALS
Conatus Pharmaceuticals is a privately-held biotechnology company focused on the development of innovative human therapeutics to treat liver disease and cancer. Their lead program, CTS-1027, is currently undergoing Phase 2 clinical trials for the treatment of Hepatitis C Virus (HCV). Conatus licensed CTS-1027 from Hoffmann-La Roche in 2006, and to date its development has been the primary focus of the Company.
CONATUS PHARMACEUTICALS
Industry:
Biotechnology Health Care Therapeutics
Founded:
2005-01-01
Address:
San Diego, California, United States
Country:
United States
Website Url:
http://www.conatuspharma.com
Total Employee:
11+
Status:
Active
Contact:
8585588920
Total Funding:
62.1 M USD
Technology used in webpage:
Domain Not Resolving Amazon GoDaddy DNS COVID-19 AWS Global Accelerator
Current Advisors List
Board_member
2011-02-01
Board_member
2011-03-01
Board_member
Board_member
2009-02-01
Board_member
2006-12-01
Current Employees Featured
Daniel Ripley Senior Director, Head of Corporate Development @ Conatus Pharmaceuticals
Senior Director, Head of Corporate Development
2012-07-01
Steven J. Mento Co-Founders, President and Chief Executive Officer, Board of Directors @ Conatus Pharmaceuticals
Co-Founders, President and Chief Executive Officer, Board of Directors
2005-07-01
Charles J. Cashion Senior Vice President, Finance, Chief Financial Officer, and Secretary , Co-Founders @ Conatus Pharmaceuticals
Senior Vice President, Finance, Chief Financial Officer, and Secretary , Co-Founders
2005-01-01
Gary C. Burgess Senior Vice President, Clinical Research, and Chief Medical Officer @ Conatus Pharmaceuticals
Senior Vice President, Clinical Research, and Chief Medical Officer
Founder
Stock Details
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2010-08-02 | Idun Pharmaceuticals | Idun Pharmaceuticals acquired by Conatus Pharmaceuticals | N/A |
Investors List
MPM Capital
MPM Capital investment in Series B - Conatus Pharmaceuticals
Gilde Healthcare
Gilde Healthcare investment in Series B - Conatus Pharmaceuticals
Bay City Capital
Bay City Capital investment in Series B - Conatus Pharmaceuticals
AgeChem Venture Fund
AgeChem Venture Fund investment in Series B - Conatus Pharmaceuticals
Advent Venture Partners
Advent Venture Partners investment in Series B - Conatus Pharmaceuticals
Aberdare Ventures
Aberdare Ventures investment in Series B - Conatus Pharmaceuticals
Roche Venture Fund
Roche Venture Fund investment in Series B - Conatus Pharmaceuticals
Gilde Healthcare
Gilde Healthcare investment in Series A - Conatus Pharmaceuticals
Bay City Capital
Bay City Capital investment in Series A - Conatus Pharmaceuticals
Aberdare Ventures
Aberdare Ventures investment in Series A - Conatus Pharmaceuticals
Official Site Inspections
http://www.conatuspharma.com
- Host name: ip87.ip-158-69-105.net
- IP address: 158.69.105.87
- Location: Montreal Canada
- Latitude: 45.4995
- Longitude: -73.5848
- Timezone: America/Toronto
- Postal: H3G
More informations about "Conatus Pharmaceuticals"
Who We Are: Discover Canadian Pharmacy | Conatuspharma.com
Canadian Pharmacy is a leading pharmacy focused on providing and promoting a wide range of innovative medicines to address various health conditions. Our commitment to offering the …See details»
Canadian Pharmacy Mart - Cost Plus Online Drugstore
Within the Canadian Pharmacy, our principal mission is to support you in attaining your personal health and wellness aspirations. We take immense pleasure in our capability to supply a …See details»
Conatus Pharmaceuticals - Crunchbase Company …
Contact Email info@conatuspharma.com Phone Number 8585588920 Conatus Pharmaceuticals is a privately-held biotechnology company focused on the …See details»
Management and Pharmacy Team | Canadian pharmacy
Conatus Pharmaceuticals | VentureRadar
Conatus Pharmaceuticals was founded in July 2005 by a cohesive and experienced team with a proven track-record in hepatology, infectious diseases and... ... Find out ...See details»
Conatus Pharmaceuticals - PitchBook
Conatus Pharmaceuticals General Information Description. Developer of human therapeutics designed to treat liver diseases. The company focuses on the development and commercialization of novel medicines to treat chronic …See details»
Conatus Pharma - Company Profile - Tracxn
Oct 22, 2024 Conatus Pharma - Speciality company that develops novel medicines for liver diseases » Conatus Pharmaceuticals, Inc.. Public Company. Raised a total funding of $67.4M …See details»
Conatus Pharmaceuticals, Inc. - Drug pipelines, Patents, Clinical ...
Explore Conatus Pharmaceuticals, Inc. with its drug pipeline, therapeutic area, technology platform, 24 clinical trials, 18 news, and 133 literature, Disease Domain ...See details»
Conatus Pharmaceuticals - Craft
May 29, 2020 Conatus Pharmaceuticals has 5 employees at their 1 location and $3.77 m in annual revenue in FY 2022. See insights on Conatus Pharmaceuticals including office …See details»
The Key Elements of Our Strategy - conatuspharma.com
Our strategy is to offer a wide range of high-quality medications for various health conditions, with a focus on excellent customer service and innovative solutions. Our approach focuses on …See details»
Conatus Pharmaceuticals Inc. | Insights
Jul 19, 2023 Already A Biomedtracker Subscriber? You have access to the full company record through your subscription.See details»
Leading Independent Proxy Advisory Firms Recommend Conatus
May 18, 2020 In addition, these documents can be obtained, without charge, by sending an e-mail to info@conatuspharma.com, along with complete contact details and a mailing address …See details»
Conatus Pharmaceuticals Raises $20 Million - Gilde Healthcare
Feb 14, 2011 Conatus’ lead drug candidate, CTS-1027 is in multiple Phase 2 clinical trials for the treatment of hepatitis C virus (HCV). Conatus was founded by the executive management …See details»
Conatus Pharmaceuticals Reports First Quarter 2020 Financial …
May 1, 2020 Conatus Pharmaceuticals Inc. (CNAT) today announced financial results for the first quarter ended March 31, 2020 and provided an update on its strategic process. In January …See details»
Conatus Pharmaceuticals and Histogen Enter into Definitive …
Jan 28, 2020 --Conatus Pharmaceuticals Inc. and Histogen Inc., a privately-held regenerative medicine company with a novel biological platform that replaces and regenerates tissues in …See details»
About Us » Strategy | Conatus Pharmaceuticals
Conatus PharmaceuticalsSee details»
Conatus Pharmaceuticals - Gilde Healthcare
Conatus Pharmaceuticals is a biotechnology company that develops and commercializes new medicines for liver disease. Gilde participated in the first financing round. The company has …See details»
Careers and Job Opportunities | Conatuspharma.com
If making a meaningful impact on people’s lives and working in a dynamic, cooperative environment excites you, Conatuspharma.com is the perfect place to grow your career! …See details»
Conatus Pharmaceuticals and Histogen Enter into Definitive
Jan 28, 2020 In addition, these documents can be obtained, without charge, by sending an e-mail to info@conatuspharma.com, along with complete contact details and a mailing address …See details»
Our Pharmacy Programs - Canadian pharmacy
These programs are tailored to meet the diverse needs of our customers, ensuring that everyone receives the care and support they deserve. Managing multiple medications can be …See details»